These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 11921432)

  • 1. Insulin resistance in type 2 diabetes: role of fatty acids.
    Arner P
    Diabetes Metab Res Rev; 2002; 18 Suppl 2():S5-9. PubMed ID: 11921432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between free fatty acids and glucose metabolism.
    Boden G
    Curr Opin Clin Nutr Metab Care; 2002 Sep; 5(5):545-9. PubMed ID: 12172479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of free fatty acids (FFA) on glucose metabolism: significance for insulin resistance and type 2 diabetes.
    Boden G
    Exp Clin Endocrinol Diabetes; 2003 May; 111(3):121-4. PubMed ID: 12784183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM.
    Boden G
    Diabetes; 1997 Jan; 46(1):3-10. PubMed ID: 8971073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty acids and insulin resistance in muscle and liver.
    Kovacs P; Stumvoll M
    Best Pract Res Clin Endocrinol Metab; 2005 Dec; 19(4):625-35. PubMed ID: 16311221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiazolidinediones attenuate lipolysis and ameliorate dexamethasone-induced insulin resistance.
    He J; Xu C; Kuang J; Liu Q; Jiang H; Mo L; Geng B; Xu G
    Metabolism; 2015 Jul; 64(7):826-36. PubMed ID: 25825274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes.
    Lewis GF; Carpentier A; Adeli K; Giacca A
    Endocr Rev; 2002 Apr; 23(2):201-29. PubMed ID: 11943743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central role of the adipocyte in insulin resistance.
    Bergman RN; Mittelman SD
    J Basic Clin Physiol Pharmacol; 1998; 9(2-4):205-21. PubMed ID: 10212835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free fatty acids and pathogenesis of type 2 diabetes mellitus.
    Bergman RN; Ader M
    Trends Endocrinol Metab; 2000 Nov; 11(9):351-6. PubMed ID: 11042464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mode of action of thiazolidinediones.
    Hauner H
    Diabetes Metab Res Rev; 2002; 18 Suppl 2():S10-5. PubMed ID: 11921433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction.
    Boden G; Shulman GI
    Eur J Clin Invest; 2002 Jun; 32 Suppl 3():14-23. PubMed ID: 12028371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Free fatty acids, insulin resistance, and type 2 diabetes mellitus.
    Boden G
    Proc Assoc Am Physicians; 1999; 111(3):241-8. PubMed ID: 10354364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nutritional effects of fat on carbohydrate metabolism.
    Boden G; Carnell LH
    Best Pract Res Clin Endocrinol Metab; 2003 Sep; 17(3):399-410. PubMed ID: 12962693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance and the effects of thiazolidinediones on cardiac metabolism.
    Young LH
    Am J Med; 2003 Dec; 115 Suppl 8A():75S-80S. PubMed ID: 14678870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatty acid-induced inflammation and insulin resistance in skeletal muscle and liver.
    Boden G
    Curr Diab Rep; 2006 Jun; 6(3):177-81. PubMed ID: 16898568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central role of the adipocyte in the metabolic syndrome.
    Bergman RN; Van Citters GW; Mittelman SD; Dea MK; Hamilton-Wessler M; Kim SP; Ellmerer M
    J Investig Med; 2001 Jan; 49(1):119-26. PubMed ID: 11217141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lowering of hepatic fatty acid uptake improves liver function and insulin sensitivity without affecting hepatic fat content in humans.
    Rigazio S; Lehto HR; Tuunanen H; Någren K; Kankaanpaa M; Simi C; Borra R; Naum AG; Parkkola R; Knuuti J; Nuutila P; Iozzo P
    Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E413-9. PubMed ID: 18505832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome, hyperinsulinemia, and cancer.
    Hsu IR; Kim SP; Kabir M; Bergman RN
    Am J Clin Nutr; 2007 Sep; 86(3):s867-71. PubMed ID: 18265480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance with aging: effects of diet and exercise.
    Ryan AS
    Sports Med; 2000 Nov; 30(5):327-46. PubMed ID: 11103847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic treatment with pioglitazone does not protect obese patients with diabetes mellitus type II from free fatty acid-induced insulin resistance.
    Serlie MJ; Allick G; Groener JE; Ackermans MT; Heijligenberg R; Voermans BC; Aerts JM; Meijer AJ; Sauerwein HP
    J Clin Endocrinol Metab; 2007 Jan; 92(1):166-71. PubMed ID: 17062758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.